Loading insider details...
Beta
Latest Form 4 (Jul 1, 2026): Disposition to Issuer of 70 APTO shares, $120.40.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 1, 2026 | Aptose Biosciences Inc. (APTO) | Disposition to Issuer | 70 | $120.40 |
| Feb 7, 2024 | Aptose Biosciences Inc. (APTO) | Grant/Award | 3,333 | n/a |
| Jan 24, 2023 | Aptose Biosciences Inc. (APTO) | Grant/Award | 100,000 | n/a |
| Jan 20, 2022 | Aptose Biosciences Inc. (APTO) | Grant/Award | 50,000 | n/a |
| Dec 21, 2021 | Aptose Biosciences Inc. (APTO) | Purchase | 10,000 | $14.5K |
| Nov 20, 2021 | Aptose Biosciences Inc. (APTO) | Exercise/Conversion | 5,417 | $11.1K |
| Jan 6, 2021 | Aptose Biosciences Inc. (APTO) | Grant/Award | 50,000 | n/a |
| Mar 13, 2020 | Aptose Biosciences Inc. (APTO) | Grant/Award | 50,000 | n/a |
| Feb 4, 2020 | Aptose Biosciences Inc. (APTO) | Grant/Award | 160,334 | n/a |